基本分析
透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。
基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
本文已翻譯成繁體中文:
Penumbra, Inc.在美國和國際上設計、開發、製造和銷售醫療器械。該公司提供基於吸引力的血栓切除系統和配件設備,包括用於機械血栓切除的再血管化設備,如Penumbra RED、JET、ACE、3D Revascularization Device和Penumbra ENGINE品牌,以及組件和配件;神經血管栓塞線圈系統,用於治療各種大小的動脈瘤和其他神經血管病變,品牌包括Penumbra Coil 400、POD400、PAC400和Penumbra SMART Coil;以及設計用於各種神經血管治療的神經血管通路系統,品牌包括Neuron、Neuron MAX、Select、BENCHMARK、BMX96、DDC和PX SLIM。
該公司還提供用於組織和液體去除的神經外科吸引工具,品牌為Artemis Neuro Evacuation Device;用於血管應用的基於吸引力的血栓切除系統,品牌為Indigo System;用於外周栓塞的可拆卸栓塞線圈系統,品牌為Ruby Coil和Ruby LP。此外,該公司還提供用於可拆卸線圈和阻塞設備遞送的微導管,品牌為LANTERN;以及設計主要用於阻塞外周血管的可拆卸、微導管可遞送的阻塞設備,品牌為POD(Penumbra Occlusion Device);以及用於促進健康、運動功能和認知的沉浸式計算機技術和沉浸式治療,品牌為Real Immersive System;以及與Ruby Coil和POD配合使用的補充性血管阻塞設備,品牌為Packing Coil和Packing Coil LP。該公司通過直銷組織和分銷商銷售其產品。Penumbra, Inc.於2004年成立,總部位於加利福尼亞州阿拉米達。
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。